| pubmed-article:20104932 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0040053 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0038257 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0070166 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:20104932 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:20104932 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20104932 | pubmed:dateCreated | 2010-1-28 | lld:pubmed |
| pubmed-article:20104932 | pubmed:abstractText | Stent thrombosis remains an important complication after stent implantation, despite the use of dual antiplatelet therapy with aspirin (acetylsalicylic acid) and clopidogrel. Several studies have shown an increased risk of thrombotic events in patients with resistance to clopidogrel. Some recent studies have suggested that a higher clopidogrel maintenance dosage could enhance ex vivo platelet inhibition and thereby overcome resistance to clopidogrel. | lld:pubmed |
| pubmed-article:20104932 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20104932 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20104932 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20104932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20104932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20104932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20104932 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20104932 | pubmed:issn | 1175-3277 | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:GalinierMiche... | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:Lapeyre-Mestr... | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:PathakAtulA | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:MontastrucJea... | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:TavassoliNeda... | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:VoisinSophieS | lld:pubmed |
| pubmed-article:20104932 | pubmed:author | pubmed-author:CarrieDidierD | lld:pubmed |
| pubmed-article:20104932 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20104932 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:20104932 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20104932 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20104932 | pubmed:pagination | 29-35 | lld:pubmed |
| pubmed-article:20104932 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:meshHeading | pubmed-meshheading:20104932... | lld:pubmed |
| pubmed-article:20104932 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20104932 | pubmed:articleTitle | High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. | lld:pubmed |
| pubmed-article:20104932 | pubmed:affiliation | Medical and Clinical Pharmacology Laboratory, Pharmacoepidemiology Unit, Faculty of Medicine, Toulouse University, Toulouse, France. neda67@yahoo.com | lld:pubmed |
| pubmed-article:20104932 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20104932 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20104932 | lld:pubmed |
